pRb, Myc and p53 are critically involved in SV40 large T antigen repression of PDGF β-receptor transcription
Open Access
- 1 August 2004
- journal article
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 117 (17) , 3855-3865
- https://doi.org/10.1242/jcs.01228
Abstract
The expression of the PDGF β-receptor is tightly regulated during a normal cell cycle. c-Myc and p73α repress transcription of the receptor through interaction with NF-Y. In ST15A cells which stably express the temperature-sensitive SV40 large T antigen (LT) the receptor expression and ligand binding decreased under the permissive condition. Transient expression of the LT, but not small t, decreased the endogenous receptor expression at mRNA and protein levels in NIH3T3 cells but not in the myc-null HO15.19 cells. The wild-type LT, but not the various pRb or p53 binding defective LT mutants, represses the PDGF β-receptor promoter activity. Moreover, the inability of the LT-mediated repression in the myc-null cells, the Rb-null 3T3 cells, and the Saos-2 cells lacking pRb and p53, indicates that Myc, pRb and p53 are all necessary elements. PDGF β-receptor promoter-luciferase assays revealed that the CCAAT motif is important for the repression. Furthermore, p53 was found to increase the promoter activity mainly via the upstream Sp1 binding sites together with the CCAAT motif in the NIH 3T3 cells. This was confirmed by Schneider's Drosophila line (SL2) cells deficient in both endogenous NF-Y and Sp1. Chromatin immunoprecipitation using ST15A cells revealed that both LT and p53 bound the PDGF β-receptor promoter and the binding of p53 diminished when LT was expressed in the permissive condition. However, LT binds the promoter in the absence of pRb and p53 in Saos-2 cells stably expressing LT. These results suggest that LT binds the promoter and interferes with NF-Y and Sp1 to repress it in the presence of Myc, pRb and p53.Keywords
This publication has 39 references indexed in Scilit:
- Functional Interaction of Nuclear Factor Y and Sp1 Is Required for Activation of the Epstein-Barr Virus C PromoterJournal of Virology, 2003
- The retinoblastoma tumour suppressor in development and cancerNature Reviews Cancer, 2002
- PDGF-D is a specific, protease-activated ligand for the PDGF β-receptorNature Cell Biology, 2001
- Loss of p19ARF Eliminates the Requirement for the pRB-Binding Motif in Simian Virus 40 Large T Antigen-Mediated TransformationMolecular and Cellular Biology, 2000
- The molecular role of Myc in growth and transformation: recent discoveries lead to new insightsThe FASEB Journal, 1998
- Isolation and Characterization of the Mouse PDGF β-Receptor PromoterBiochemical and Biophysical Research Communications, 1995
- Inactivation of p53 gene in human and murine osteosarcoma cellsBritish Journal of Cancer, 1992
- Quantitative determination of mRNA phenotypes by the polymerase chain reactionAnalytical Biochemistry, 1991
- Analysis of Sp1 in vivo reveals mutiple transcriptional domains, including a novel glutamine-rich activation motifCell, 1988
- Immortalization of precursor cells from the mammalian CNSNeuron, 1988